Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centinel Spine is a privately held medical device company focused on anterior column reconstruction for cervical and lumbar spinal disease. The company commercializes motion-preserving total disc replacement systems under the prodisc brand and has historically also marketed integrated interbody fusion products under the STALIF brand. In 2023, Centinel divested its global fusion business to Silony Spine and sharpened its focus on motion-preservation technologies. Its current business centers on commercially available cervical and lumbar total disc replacement implants, including products in the prodisc C and prodisc L portfolios, for surgeons treating degenerative disc disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sentinel Spine.